Factor VIII inhibitor: Difference between revisions
No edit summary |
|||
Line 11: | Line 11: | ||
==Management== | ==Management== | ||
*Bleeding | *Bleeding | ||
** | **Give high dose Factor VII, prothrombin, or recombinant factor VIIa | ||
==Disposition== | ==Disposition== |
Revision as of 12:59, 10 June 2015
Background
Clinical Features
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Diagnosis
- PTT does not correct after mixing
Management
- Bleeding
- Give high dose Factor VII, prothrombin, or recombinant factor VIIa